(Q39253744)

10 September 2017

title

Exendin-4 inhibits iNOS expression at the protein level in LPS-stimulated Raw264.7 macrophage by the activation of cAMP/PKA pathway (English)

1 reference

10 September 2017

0 references

5

1 reference

10 September 2017

Seo-Yoon Chang

1

1 reference

10 September 2017

Dong-Bin Kim

2

1 reference

10 September 2017

Gyeong Ryul Ryu

3

1 reference

10 September 2017

Seung-Hyun Ko

4

1 reference

10 September 2017

Yu-Bae Ahn

6

1 reference

10 September 2017

Yang-Hyeok Jo

7

1 reference

10 September 2017

Myung-Jun Kim

8

1 reference

10 September 2017

publication date

1 April 2013

1 reference

Journal of Cellular Biochemistry

10 September 2017

published in

1 reference

10 September 2017

volume

114

1 reference

10 September 2017

issue

4

1 reference

10 September 2017

page(s)

844-853

1 reference

Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4.

10 September 2017

cites work

1 reference

Nitric oxide and the immune response

21 January 2018

1 reference

Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system

21 January 2018

1 reference

The role of GLP-1 in the regulation of islet cell mass.

21 January 2018

1 reference

Exendin-4 attenuates lipopolysaccharides induced inflammatory response but does not protects H9c2 cells from apoptosis

21 January 2018

1 reference

Effects of glucagon-like peptide 1 on the hepatic glucose metabolism

21 January 2018

1 reference

The biology of incretin hormones

21 January 2018

1 reference

Oxalomalate affects the inducible nitric oxide synthase expression and activity

21 January 2018

1 reference

Compounds that increase or mimic cyclic adenosine monophosphate enhance tristetraprolin degradation in lipopolysaccharide-treated murine j774 macrophages

21 January 2018

1 reference

cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2.

21 January 2018

1 reference

Rapamycin down-regulates inducible nitric oxide synthase by inducing proteasomal degradation

21 January 2018

1 reference

Upregulation of rat Ccnd1 gene by exendin-4 in pancreatic beta cell line INS-1: interaction of early growth response-1 with cis-regulatory element

21 January 2018

1 reference

Exendin-4 inhibits interleukin-1beta-induced iNOS expression at the protein level, but not at the transcriptional and posttranscriptional levels, in RINm5F beta-cells.

21 January 2018

1 reference

Inhibitory effects of epicatechin on interleukin-1beta-induced inducible nitric oxide synthase expression in RINm5F cells and rat pancreatic islets by down-regulation of NF-kappaB activation

21 January 2018

1 reference

Exendin-4 induction of cyclin D1 expression in INS-1 beta-cells: involvement of cAMP-responsive element

21 January 2018

1 reference

Exendin-4 induction of Egr-1 expression in INS-1 beta-cells: interaction of SRF, not YY1, with SRE site of rat Egr-1 promoter

21 January 2018

1 reference

Regulation of the expression of inducible nitric oxide synthase

21 January 2018

1 reference

Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes

21 January 2018

1 reference

Macrophages and inflammatory mediators in tissue injury

21 January 2018

1 reference

NF-kappaB regulation in the immune system

21 January 2018

1 reference

Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B.

21 January 2018

1 reference

Glucagon-like peptide 1 agonists and the development and growth of pancreatic beta-cells

21 January 2018

1 reference

Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774

21 January 2018

1 reference

Natural antisense transcript stabilizes inducible nitric oxide synthase messenger RNA in rat hepatocytes

21 January 2018

1 reference

Cytokines and autoimmunity

21 January 2018

1 reference

Dexamethasone inhibits the induction of iNOS gene expression through destabilization of its mRNA in proinflammatory cytokine-stimulated hepatocytes

21 January 2018

1 reference

Repression of inducible nitric oxide synthase and cyclooxygenase-2 by prostaglandin E2 and other cyclic AMP stimulants in J774 macrophages

21 January 2018

1 reference

PPARalpha agonists inhibit nitric oxide production by enhancing iNOS degradation in LPS-treated macrophages.

21 January 2018

1 reference

The polypyrimidine tract-binding protein (PTB) is involved in the post-transcriptional regulation of human inducible nitric oxide synthase expression.

21 January 2018

1 reference

Excessive islet NO generation in type 2 diabetic GK rats coincides with abnormal hormone secretion and is counteracted by GLP-1.

21 January 2018

1 reference

Cyclic AMP signaling stimulates proteasome degradation of thioredoxin interacting protein (TxNIP) in pancreatic beta-cells

21 January 2018

1 reference

The cytokine responsive vascular smooth muscle cell enhancer of inducible nitric oxide synthase. Activation by nuclear factor-kappa B.

21 January 2018

1 reference

Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons

21 January 2018

1 reference

Exenatide sensitizes insulin-mediated whole-body glucose disposal and promotes uptake of exogenous glucose by the liver

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCB.24425

1 reference

10 September 2017

1 reference